DOI QR코드

DOI QR Code

Prognostic Implication of QRS Variability during Hospitalization in Patients with Acute Decompensated Heart Failure

  • Lee, So-Ryoung (Department of Internal Medicine, Seoul National University Hospital) ;
  • Choi, Eue-Keun (Department of Internal Medicine, Seoul National University Hospital) ;
  • Kang, Do-Yoon (Department of Internal Medicine, Seoul National University Hospital) ;
  • Cha, Myung-Jin (Department of Internal Medicine, Seoul National University Hospital) ;
  • Cho, Youngjin (Department of Internal Medicine, Seoul National University Hospital) ;
  • Oh, Il-Young (Cardiovascular Center, Seoul National University Bundang Hospital) ;
  • Oh, Seil (Department of Internal Medicine, Seoul National University Hospital)
  • 투고 : 2013.07.10
  • 심사 : 2013.11.18
  • 발행 : 2014.01.30

초록

Background and Objectives: Heart failure (HF) patients display more varied QRS duration. We investigated whether QRS variability during hospitalization for acute decompensated HF is associated with poor clinical outcomes after discharge. Subjects and Methods: One hundred seventy three patients (64% males; age $60{\pm}13$ years) admitted for acute decompensated HF with severe left ventricular (LV) dysfunction (LV ejection fraction ${\leq}35%$) were consecutively enrolled. QRS variability was calculated by the difference between maximum and minimum QRS duration acquired during hospitalization. The prognostic implications on composite endpoints of death or urgent heart transplantation were analyzed. Results: Forty-two patients (24.3%) died and three patients (1.7%) underwent urgent heart transplantation during the follow-up of $51{\pm}18$ months. Patients who reached composite endpoints (n=45) showed greater QRS variability than those who did not (n=128) ($20{\pm}23ms$ vs. $14{\pm}14ms$, p=0.046). Patients who had high QRS variability (more than 22 ms; n=36) tended to have a higher event rate than those with QRS variability <22 ms {39% vs. 23%, hazard ratio (HR), 1.88; 95% confidence interval (CI) 1.001-3.539, p=0.05}. Adjusting with other variables, high QRS variability was an independent predictor for composite outcome (HR 1.94; 95% CI 1.023-3.683, p=0.042). Conclusion: QRS variability measured during hospitalization for acute decompensated HF has a prognostic impact in HF patients with severe LV dysfunction.

키워드

과제정보

연구 과제 주관 기관 : Seoul National University Hospital

참고문헌

  1. Cleland JG, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999;1:229-41. https://doi.org/10.1016/S1388-9842(99)00032-X
  2. Shenkman HJ, Pampati V, Khandelwal AK, et al. Congestive heart failure and QRS duration: establishing prognosis study. Chest 2002;122: 528-34. https://doi.org/10.1378/chest.122.2.528
  3. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005;46:2183-92. https://doi.org/10.1016/j.jacc.2005.01.071
  4. Murkofsky RL, Dangas G, Diamond JA, Mehta D, Schaffer A, Ambrose JA. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction. J Am Coll Cardiol 1998;32: 476-82. https://doi.org/10.1016/S0735-1097(98)00242-3
  5. Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol 2004;93:244-6. https://doi.org/10.1016/j.amjcard.2003.09.053
  6. Brilakis ES, Mavrogiorgos NC, Kopecky SL, et al. Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction. Am J Cardiol 2002;89:1013-8. https://doi.org/10.1016/S0002-9149(02)02267-1
  7. Kalra PR, Sharma R, Shamim W, et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 2002;86:225-31. https://doi.org/10.1016/S0167-5273(02)00270-X
  8. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN; Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002;143:1085-91. https://doi.org/10.1067/mhj.2002.122516
  9. Bleeker GB, Schalij MJ, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2004;15:544-9. https://doi.org/10.1046/j.1540-8167.2004.03604.x
  10. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. https://doi.org/10.1056/NEJMoa050496
  11. Sipahi I, Carrigan TP, Rowland DY, Stambler BS, Fang JC. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 2011;171:1454-62. https://doi.org/10.1001/archinternmed.2011.247
  12. Aranda JM, Carlson ER, Pauly DF, et al. QRS duration variability in patients with heart failure. Am J Cardiol 2002;90:335-7. https://doi.org/10.1016/S0002-9149(02)02479-7
  13. Wang NC, Maggioni AP, Konstam MA, et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA 2008;299:2656-66. https://doi.org/10.1001/jama.299.22.2656
  14. Barsheshet A, Goldenberg I, Garty M, et al. Relation of bundle branch block to long-term (four-year) mortality in hospitalized patients with systolic heart failure. Am J Cardiol 2011;107:540-4. https://doi.org/10.1016/j.amjcard.2010.10.007
  15. McCullough PA, Hassan SA, Pallekonda V, et al. Bundle branch block patterns, age, renal dysfunction, and heart failure mortality. Int J Cardiol 2005;102:303-8. https://doi.org/10.1016/j.ijcard.2004.10.008
  16. Baldasseroni S, Gentile A, Gorini M, et al. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J 2003;4:607-13.
  17. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol 2009;53:557-73. https://doi.org/10.1016/j.jacc.2008.10.041
  18. Lee CW, Lee JH, Lim TH, et al. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. Circulation 2001;103:2784-7. https://doi.org/10.1161/01.CIR.103.23.2784
  19. Gulati A, Ismail TF, Jabbour A, et al. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation 2013;128:1623-33. https://doi.org/10.1161/CIRCULATIONAHA.113.002518
  20. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992; 123:421-6. https://doi.org/10.1016/0002-8703(92)90656-G
  21. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235. https://doi.org/10.1161/CIRCULATIONAHA.105.167586
  22. Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart 2002;88: 47-51. https://doi.org/10.1136/heart.88.1.47
  23. Xiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996;53:163-70. https://doi.org/10.1016/0167-5273(95)02502-2
  24. Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825-31. https://doi.org/10.1016/S0735-1097(98)00492-6
  25. Horwich T, Lee SJ, Saxon L. Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies. Am J Cardiol 2003;92: 804-9. https://doi.org/10.1016/S0002-9149(03)00887-7